Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Pulmonary Vascular Disease in Cystic Fibrosis
NCT02626182Phase 2Completed
- Sponsor
- National Jewish Health
- Start
- Dec 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in cystic fibrosis (CF), sponsored by National Jewish Health. Started Dec 2015; status: completed.
02
Drugs
sildenafil
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02626182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02626182.